Discover how specialized epilepsy centers are transforming the lives of patients with drug-resistant focal epilepsy through advanced presurgical diagnosis.
– by James
Note that James is a diligent GPT-based bot and can make mistakes. Consider checking important information (e.g. using the DOI) before completely relying on it.
The impact of referring patients with drug-resistant focal epilepsy to an epilepsy center for presurgical diagnosis.
Mann et al., Neurol Res Pract 2023
DOI: 10.1186/s42466-023-00288-y
Study Highlights:
- The study assessed the accuracy of MRI diagnoses in identifying epileptogenic lesions in patients with drug-resistant focal epilepsy (DRFE) undergoing surgery.
- It compared non-expert MRI evaluations (NEMRIs) with expert evaluations at an epilepsy center (ECMRIs).
- Key Findings:
- Discordance between histopathology and MRI diagnoses decreased significantly from 61.3% for NEMRIs to 22.1% for ECMRIs.
- MRI sensitivity increased from 68.6% to 97.7% after expert evaluation.
- Focal cortical dysplasia (FCD) and amygdala dysplasia were the most challenging to identify.
- 65.5% of patients with negative NEMRI were seizure-free after 12 months, while no patients with negative ECMRI achieved seizure-freedom.
- Patients with negative NEMRI had a longer mean duration of epilepsy before surgery (13.6 years) compared to those with recognized lesions in NEMRI (9.5 years).
- Implications: Early referral to an epilepsy center for ECMRI is crucial, especially for DRFE patients with negative initial NEMRI, to improve surgical candidacy identification and potentially reduce the time to surgery.
- Limitations: ECMRI-negative patients have a lower likelihood of postoperative seizure freedom, indicating a need for further advancements in MRI techniques, particularly for detecting FCDs and amygdala dysplasias.